{"pageContent": "Aims: High intensity focused ultrasound (HIFU) is currently offered as primary treatment for patients with clinically localised prostate cancer. Data on histopathological features of post-treatment biopsies are limited.", "metaData": {"source": "Role of MRI in follow-up after focal therapy for prostate carcinoma\nhttps://pubmed.ncbi.nlm.nih.gov/20489080/"}}